Combination Therapy Reduced HER2-Positive Breast Cancers
Links shared publicly online about this topic.
- 662total visits
Combination Therapy Reduced HER2-Positive Breast Cancers
View full resource at medicalnewstoday.com
Tags: Cancer, Cancer Medication, Breast Cancer, Breast Cancer Medication, Women's Health, Herceptin, Taxol
Most Recently Shared on December 11, 2010 at 6:05 pm By:
Combination Therapy Reduced HER2-Positive Breast Cancers http://mnt.to/3NXF #medicalconferences
Also Shared By:
Adjuvant Therapy for Small HER2-Positive Breast Cancers | GRACE :: Breast Cancer
cancergrace.org — “Herceptin (Trastuzumab), the antibody against the HER2/neu protein over-expressed in about 20-30% of breast cancers, has been shown to reduce the risk of” View full resource at cancergrace.org
Most Recently Shared on October 1, 2011 at 1:55 pm By:
Denise Brock - GRACE Health Organization
Dr. Mary Cianfrocca, breast cancer expert, discusses adjuvant (post-operative) management of small... http://t.co/3y6BDgtJ
Estrogen Lowers Risk of Heart Attack and Breast Cancer in Some - NYTimes.com
well.blogs.nytimes.com — “Women in a major study who had hysterectomies and took only estrogen rather than a combination of hormones had reduced risk of breast cancer and heart attack. The finding challenges conventional wisdom about the risks of hormone therapy for menopause.” View full resource at well.blogs.nytimes.com
Most Recently Shared on April 10, 2011 at 1:12 am By:
Debby Verville Health Advocate
Estrogen Lowers Risk of Heart Attack and Breast Cancer in Some - NYTimes.com http://nyti.ms/eSeyxB
Estrogen Lowers Risk of Heart Attack and Breast Cancer in Some - NYTimes.com
well.blogs.nytimes.com — “Women in a major study who had hysterectomies and took only estrogen rather than a combination of hormones had reduced risk of breast cancer and heart attack. The finding challenges conventional wisdom about the risks of hormone therapy for menopause.” View full resource at well.blogs.nytimes.com
Most Recently Shared on April 6, 2011 at 9:24 pm By:
NYTimes Science Science Enthusiast
Well: Estrogen Lowers Breast Cancer and Heart Risk in Some http://nyti.ms/i45dP3
Estrogen Lowers Risk of Heart Attack and Breast Cancer in Some - NYTimes.com
well.blogs.nytimes.com — “Women in a major study who had hysterectomies and took only estrogen rather than a combination of hormones had reduced risk of breast cancer and heart attack. The finding challenges conventional wisdom about the risks of hormone therapy for menopause.” View full resource at well.blogs.nytimes.com
Most Recently Shared on April 6, 2011 at 1:05 pm By:
Susan Krauss Whitbourne Doctor, Psychologist, and PhD
New research on #estrogen suggests fewer risks and possible benefits: http://ow.ly/4ufrn #health #women #aging
Estrogen Lowers Risk of Heart Attack and Breast Cancer in Some - NYTimes.com
well.blogs.nytimes.com — “Women in a major study who had hysterectomies and took only estrogen rather than a combination of hormones had reduced risk of breast cancer and heart attack. The finding challenges conventional wisdom about the risks of hormone therapy for menopause.” View full resource at well.blogs.nytimes.com
Most Recently Shared on April 6, 2011 at 12:38 pm By:
MadeleineCastellanos Doctor, Psychiatrist, and Physician
Study shows that estrogen replacement in menopause (without progesterone) actually lowered risk of breast cancer http://nyti.ms/hAU4m6
Estrogen Lowers Risk of Heart Attack and Breast Cancer in Some - NYTimes.com
well.blogs.nytimes.com — “Women in a major study who had hysterectomies and took only estrogen rather than a combination of hormones had reduced risk of breast cancer and heart attack. The finding challenges conventional wisdom about the risks of hormone therapy for menopause.” View full resource at well.blogs.nytimes.com
Most Recently Shared on April 5, 2011 at 8:33 pm By:
Well: Estrogen Lowers Heart and Cancer Risks in Some http://nyti.ms/gCyssN
Hit multiple targets for maximum benefit in HER2-positive breast cancer, studies suggest
sciencedaily.com — “Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies.” View full resource at sciencedaily.com
Most Recently Shared on March 8, 2011 at 8:18 pm By:
Hit multiple targets for maximum benefit in HER2-positive breast cancer, studies suggest: Combining targeted the... http://bit.ly/g6S1EV
Hit multiple targets for maximum benefit in HER2-positive breast cancer, studies suggest
physorg.com — “Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center (VICC) investigators.” View full resource at physorg.com
Most Recently Shared on March 8, 2011 at 2:51 pm By:
Hit multiple targets for maximum benefit in HER2-positive breast cancer, studies suggest http://bit.ly/h6bLAS
Combination therapy reduced HER2-positive breast cancers
sciencedaily.com — “A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to new data.” View full resource at sciencedaily.com
Most Recently Shared on December 10, 2010 at 3:17 pm By:
Combination therapy reduced HER2-positive breast cancers: A combination of lapatinib, trastuzumab and paclitaxel... http://bit.ly/hjR0jl
Combination Therapy Reduced HER2-Positive Breast Cancers
newswise.com — “1) Three drug combination worked better than when used alone. 2) Surgical remission rate was 50 percent, but was 20 percent with single therapy.” View full resource at newswise.com
Most Recently Shared on December 10, 2010 at 2:44 pm By:
newswise Health Communicator and Health News
Combination Therapy Reduced HER2-Positive Breast Cancers: 1) Three drug combination worked better than when used... http://bit.ly/efAKTi
Flesh and Stone - Researchers: Future therapies for aggressive breast cancer can be more effective and much less toxic
fleshandstone.net — “A combination of two existing cancer drugs for treating HER2-positive metastatic cancer, an aggressive form of breast cancer, performed better and were less toxic than standard therapies, according to researcher Edith Perez, MD, of the Mayo Clinic in Flor” View full resource at fleshandstone.net
Most Recently Shared on October 10, 2010 at 10:53 pm By:
stonekat Health Communicator and Health News
Researchers: Future therapies for aggressive breast cancer can be more effective and much less toxic http://t.co/WecVmFE
Touch Therapies Reduce Secondary Lymphedema
massagemag.com — “Many women who have breast-cancer surgery that involves the dissection of axillary lymph nodes develop secondary lymphedema. New research shows a combination of massage therapy, manual lymph drainage and assisted shoulder exercises reduced the development of secondary lymphedema for at least one year after breast-cancer surgery.” View full resource at massagemag.com
Most Recently Shared on July 27, 2010 at 5:42 pm By:
MASSAGE Magazine Health Magazine
Touch Therapies Reduce Secondary Lymphedema http://fb.me/sDcuyFno
FDA Expands Use of Approved Breast Cancer Drug
tweetmeme.com — “The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.HER2 is a” View full resource at tweetmeme.com
Most Recently Shared on February 2, 2010 at 5:36 pm By:
Healthcare TweetMeme Health Social Media
FDA Expands Use of Approved Breast Cancer Drug http://retwt.me/1LQFf (via @FightPink)
FDA Expands Use of Approved Breast Cancer Drug
fda.gov — “The u.s. food and drug administration today approved tykerb (lapatinib) in combination with femara (letrozole) to treat hormone positive and her2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.” View full resource at fda.gov
Most Recently Shared on January 29, 2010 at 11:42 pm By:
FDA Expands Use of Approved Breast Cancer Drug http://bit.ly/by1mT7
Advertisement
MNT Breast Cancer
@mnt_breastcance
Combination Therapy Reduced HER2-Positive Breast Cancers http://mnt.to/3NXF #breastcancer
1 year ago...